NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 10th Nov 2025 NOVO-B STOCK Price closed @ 294.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 748.89 & Strong Sell for SHORT-TERM with Stoploss of 944.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 298.75 Change Price %
High 302.20 1 Day 3.50 1.20
Low 294.70 1 Week -28.00 -8.68
Close 294.70 1 Month -56.80 -16.16
Volume 7869151 1 Year -616.80 -67.67
52 Week High 1028.00 | 52 Week Low 289.50
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 294.70 1.20%
CONFRZ 0.02 0.00%
VWS 154.00 1.58%
AMBU-B 82.45 0.86%
STENO 2.46 28.12%
ORSTED 122.40 4.13%
GN 103.45 1.32%
DANSKE 292.70 0.58%
GREENH 0.41 -6.82%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
STENO 2.46 28.12%
HYPE 3.66 22.00%
MONSO 0.13 18.18%
DKIEEU 249.00 15.81%
FASTPC 19.80 14.45%
MDUNDO 4.20 11.70%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE309.15
RESISTANCE304.52
RESISTANCE301.65
RESISTANCE298.79
SUPPORT290.61
SUPPORT287.75
SUPPORT284.88
SUPPORT280.25
 
NOVO-B Forecast November 2025
4th UP Forecast578.93
3rd UP Forecast487.78
2nd UP Forecast431.43
1st UP Forecast375.09
1st DOWN Forecast214.31
2nd DOWN Forecast157.97
3rd DOWN Forecast101.62
4th DOWN Forecast10.47
 
NOVO-B Weekly Forecast
4th UP Forecast453.68
3rd UP Forecast402.69
2nd UP Forecast371.18
1st UP Forecast339.66
1st DOWN Forecast249.74
2nd DOWN Forecast218.22
3rd DOWN Forecast186.71
4th DOWN Forecast135.72
 
NOVO-B Forecast2025
4th UP Forecast1731.47
3rd UP Forecast1270.69
2nd UP Forecast985.87
1st UP Forecast701.05
1st DOWN Forecast-111.65
2nd DOWN Forecast-396.47
3rd DOWN Forecast-681.29
4th DOWN Forecast-1142.07
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service